DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the SHEEL BIOTECH LIMITED (SHEEL) share price today?

SHEEL BIOTECH LIMITED (SHEEL) is trading at ₹70.25 on the NSE, down 2.43% on the day. Source: DocStoX.

What is the PE ratio of SHEEL BIOTECH LIMITED?

SHEEL BIOTECH LIMITED has a price-to-earnings (PE) ratio of 9.9 in the Commercial Services sector.

What is the market capitalisation of SHEEL BIOTECH LIMITED?

SHEEL BIOTECH LIMITED has a market capitalisation of approximately ₹142 crore.

SHEEL BIOTECH LIMITED

SHEEL·NSE·Commercial Services

₹70.25▼ -1.75 (-2.43%)

Commercial Services · Diversified Services

A steady, established business

52W₹38

₹9656%

Open

₹70.25

High

₹70.25

Low

₹70.25

Prev Close

₹72.00

Volume

2.0K

VWAP

₹70.25

Snapshot

Key fundamentals

Market Cap

₹142 Cr

P/E Ratio

9.87Cheap

P/B Ratio

1.12

EPS

₹7.12

Book Value

₹62.40

ROE

14.00%Average

ROCE

14.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.20Low

Face Value

₹10.00

52W High

₹95.55

52W Low

₹37.80

Sector

Commercial Services

Industry

Diversified Services

Fairly Valued

None moatMedium uncertainty

Fair value estimate

₹69

▼ 2.0%downside

Trading at ₹70 — 2% above our estimate

BearFair valueBull

₹59₹69₹90

/100

Business quality — Watch the fundamentals

Growth 17Profitability 45Efficiency 15Valuation 95

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 1/9)

Strengths

Low debt relative to equity
Reasonably priced at 10× earnings
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

13% ROE fading to 12% over ~3 yrs, on ₹62 book

₹63

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹90

Analyst target

No analyst coverage

—

Blended fair value₹69

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Reasonably priced at 10× earnings
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

9.9Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

14.0%Average

Above 15% is considered healthy for Indian equities

ROCE

14.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.20Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹142 Cr

P/B

1.12

EPS

₹7.12

Div Yield

—

What changed

Recent changes

Foreign investors-2.3% stake last quarter
Domestic institutions-0.8% stake last quarter
Promoters+1.04% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 9.9×

Growth

Slow

+2% rev CAGR

Profitability

Healthy

14.0% ROE

Financial health

Rock solid

D/E 0.20

Momentum

N/A

No technicals

Today

Trading activity

Delivery %100.0%

Turnover₹1.41L Cr

Trades1

VWAP₹70.25

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+2.2%

+5.5%

10Y

—

Profit

+5.0%

+18.3%

10Y

—

EPS

-38.8%

-11.9%

10Y

—

Profile

Pros

Company has delivered good profit growth of 20.1% CAGR over last 5 years
Promoter holding has increased by 1.04% over last quarter.

Watch-outs

Cons

The company has delivered a poor sales growth of 11.8% over past five years.
Company has high debtors of 183 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 1.04 pts; foreign investors sold 2.28 pts; domestic institutions reduced 0.76 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

72%

Promoter

Promoters

72.3%+1.04

Public

10.9%-1.20

FII / FPI

0.0%-2.28

DII

9.5%-0.76

Others

7.3%

Total shareholders

395-241 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter72.30%

DII9.49%

Public10.89%

Others7.32%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in November 199, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]